Cytomegalovirus
(CMV) retinitis is a potentially blinding disease that effects immunocompromised
hosts, most commonly those infected with the human immunodifficiency
virus (HIV). CMV retinitis affects 20-40% of HIV+ patients diagnosed
with AIDS.
 Treatment
options include intravenous (IV) therapy with gancyclovir, foscarnate
or cidofovir. More recently, oral treatment with gancyclovir and a
prodrug formulation of gancyclovir have been used and are currently
being evaluated for their safety and efficacy. In addition, the gancyclovir
implant has been used to deliver high local therapy for this intraocular
disease. The Rretina-VitreousAssociates are national leaders in the
study and treatment of CMV retinitis. |
Our
services
The Retina
Diabetic Retinopathy
Macular Diseases
Strokes of the Retina
Floaters and Flashes
Retinal Detachment
CMV retinitis
Uveitis
Eye Surgery
The Hospital Stay
|
